Device type · NIU
Stent, Superficial Femoral Artery, Drug-Eluting
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
NIU
Cardiovascular
Device class
Class III
FDA decisions since 2015
2
510(k), De Novo and PMA
Adverse event reports
137
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Stent, Superficial Femoral Artery, Drug-Eluting
- Product code
- NIU
- Device class
- Class III
- Review panel
- Cardiovascular
- Specialty
- Cardiology, Interventional Cardiology
- FDA record
- Classification database entry for NIU
Latest FDA decisions
P180011 · Decided Sep 18, 2018 · 158 days after receipt
Device type: Stent, superficial femoral artery, drug-eluting (NIU) · Cardiology
1 more FDA decisions with a free account
Reports received
137
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
51
37% of reports
Injury reports
84
61% of reports
Death reports
2
1.5% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 9 | 21 | 0 | 0 |
| Jan 24 | 6 | 7 | 0 | 0 |
| Feb 24 | 7 | 9 | 0 | 0 |
| Mar 24 | 2 | 5 | 3 | 0 |
| Apr 24 | 3 | 13 | 0 | 0 |
| May 24 | 7 | 8 | 0 | 0 |
| Jun 24 | 6 | 6 | 0 | 0 |
| Jul 24 | 10 | 8 | 0 | 0 |
| Aug 24 | 9 | 21 | 0 | 0 |
| Sep 24 | 5 | 13 | 0 | 0 |
| Oct 24 | 6 | 9 | 0 | 0 |
| Nov 24 | 2 | 2 | 0 | 0 |
| Dec 24 | 5 | 3 | 0 | 0 |
| Jan 25 | 3 | 14 | 0 | 0 |
| Feb 25 | 4 | 11 | 0 | 0 |
| Mar 25 | 6 | 11 | 0 | 0 |
| Apr 25 | 5 | 13 | 0 | 0 |
| May 25 | 7 | 10 | 0 | 0 |
| Jun 25 | 5 | 10 | 0 | 0 |
| Jul 25 | 3 | 24 | 1 | 0 |
| Aug 25 | 2 | 4 | 0 | 0 |
| Sep 25 | 6 | 18 | 0 | 0 |
| Oct 25 | 3 | 5 | 0 | 0 |
| Nov 25 | 0 | 6 | 0 | 0 |
| Dec 25 | 6 | 6 | 0 | 0 |
| Jan 26 | 8 | 4 | 0 | 0 |
| Feb 26 | 2 | 12 | 1 | 0 |
| Mar 26 | 8 | 14 | 0 | 0 |
| Apr 26 | 4 | 3 | 0 | 0 |
| May 26 | 2 | 8 | 0 | 0 |
| Jun 26 | 2 | 5 | 0 | 0 |
| Jul 26 | 4 | 5 | 1 | 0 |
| Aug 26 | 4 | 7 | 0 | 0 |
| Sep 26 | 3 | 9 | 0 | 0 |
| Oct 26 | 8 | 5 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
The full in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem63
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions68
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1621-2021 · Started Apr 21, 2021
Reason given: One batch of the ELUVIATM Drug Eluting Vascular Stent System incorrect placement of some 6x40mm ELUVIA stents into 6x100mm packaging.
Cause as FDA categorized it: Reprocessing Controls
2 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.